{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:56:08Z","timestamp":1773762968356,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-15675-2","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:24:24Z","timestamp":1770711864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering the eRNA landscape and revealing target aberrant pathways in prostate cancer"],"prefix":"10.1186","volume":"26","author":[{"given":"Chengling","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baiyang","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixing","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zejun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"issue":"3","key":"15675_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H SUNG","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"2","key":"15675_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S1470-2045(21)00705-1","volume":"23","author":"Y KISHAN A U, SUN","year":"2022","unstructured":"Kishan AU, Sun Y, Hartman H, et al. Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis. Lancet Oncol. 2022;23(2):304\u201316.","journal-title":"Lancet Oncol"},{"issue":"6","key":"15675_CR3","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41594-020-0446-0","volume":"27","author":"V SARTORELLI","year":"2020","unstructured":"Sartorelli V, Lauberth SM. Enhancer RNAs are an important regulatory layer of the epigenome. Nat Struct Mol Biol. 2020;27(6):521\u20138.","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"15675_CR4","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.1038\/s41467-019-12543-5","volume":"10","author":"Z ZHANG","year":"2019","unstructured":"Zhang Z, Lee JH, Ruan H, et al. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer. Nat Commun. 2019;10(1):4562.","journal-title":"Nat Commun"},{"issue":"7295","key":"15675_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature09033","volume":"465","author":"M KIM T K, HEMBERG","year":"2010","unstructured":"Kim TK, Hemberg M, Gray JM, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465(7295):182\u20137.","journal-title":"Nature"},{"issue":"16","key":"15675_CR6","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1016\/j.molcel.2021.07.024","volume":"81","author":"JH LEE","year":"2021","unstructured":"Lee JH, Wang R, Xiong F, et al. Enhancer RNA m6A methylation facilitates transcriptional condensate formation and gene activation. Mol Cell. 2021;81(16):3368\u2013e859.","journal-title":"Mol Cell"},{"issue":"11","key":"15675_CR7","doi-asserted-by":"publisher","first-page":"110944","DOI":"10.1016\/j.celrep.2022.110944","volume":"39","author":"WL HOU T Y, KRAUS","year":"2022","unstructured":"Hou TY, Kraus WL. Analysis of estrogen-regulated enhancer RNAs identifies a functional motif required for enhancer assembly and gene expression. Cell Rep. 2022;39(11):110944.","journal-title":"Cell Rep"},{"issue":"D1","key":"15675_CR8","doi-asserted-by":"publisher","first-page":"D882","DOI":"10.1093\/nar\/gkz1062","volume":"48","author":"Y LUO","year":"2020","unstructured":"Luo Y, Hitz BC, Gabdank I, et al. New developments on the encyclopedia of DNA elements (ENCODE) data portal. Nucleic Acids Res. 2020;48(D1):D882\u20139.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"15675_CR9","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/nar\/gkw855","volume":"45","author":"M MALINEN","year":"2017","unstructured":"Malinen M, Niskanen EA, Kaikkonen MU, et al. Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-kappaB cistrome to reprogram the prostate cancer cell transcriptome. Nucleic Acids Res. 2017;45(2):619\u201330.","journal-title":"Nucleic Acids Res"},{"key":"15675_CR10","doi-asserted-by":"crossref","unstructured":"Lee HN, Choi YY, Kim JW, et al. Effect of biochemical and Biomechanical factors on vascularization of kidney organoid-on-a-chip. Nano Convergence. 2021;8(1).","DOI":"10.1186\/s40580-021-00285-4"},{"issue":"7414","key":"15675_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"CONSORTIUM E P","year":"2012","unstructured":"Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature. 2012;489(7414):57\u201374.","journal-title":"Nature"},{"issue":"8","key":"15675_CR12","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/gb-2011-12-8-r83","volume":"12","author":"T LIU","year":"2011","unstructured":"Liu T, Ortiz JA, Taing L, et al. Cistrome: an integrative platform for transcriptional regulation studies. Genome Biol. 2011;12(8):R83.","journal-title":"Genome Biol"},{"issue":"D1","key":"15675_CR13","doi-asserted-by":"publisher","first-page":"D287","DOI":"10.1093\/nar\/gkab702","volume":"50","author":"W ZHAO","year":"2022","unstructured":"Zhao W, Zhang S, Zhu Y, et al. POSTAR3: an updated platform for exploring post-transcriptional regulation coordinated by RNA-binding proteins. Nucleic Acids Res. 2022;50(D1):D287\u201394.","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"15675_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"W LOVE M I, HUBER","year":"2014","unstructured":"Love MI, Huber W. Moderated Estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"17","key":"15675_CR15","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1093\/bioinformatics\/btv300","volume":"31","author":"W WALTER","year":"2015","unstructured":"Walter W, Sanchez-Cabo F Ricotem. GOplot: an R package for visually combining expression data with functional analysis. Bioinformatics. 2015;31(17):2912\u20134.","journal-title":"Bioinformatics"},{"issue":"24","key":"15675_CR16","doi-asserted-by":"publisher","first-page":"3982","DOI":"10.1093\/bioinformatics\/btx513","volume":"33","author":"Y TIAN","year":"2017","unstructured":"Tian Y, Morris TJ, Webster AP, et al. Champ: updated methylation analysis pipeline for illumina beadchips. Bioinformatics. 2017;33(24):3982\u20134.","journal-title":"Bioinformatics"},{"issue":"11","key":"15675_CR17","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A MAYAKONDA","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"key":"15675_CR18","doi-asserted-by":"crossref","unstructured":"Dorighi KM, Swigut T, Henriques T, et al. Mll3 and Mll4 facilitate enhancer RNA synthesis and transcription from promoters independently of H3K4 monomethylation. Mol Cell. 2017;66(4):568\u201376e4.","DOI":"10.1016\/j.molcel.2017.04.018"},{"issue":"20","key":"15675_CR19","doi-asserted-by":"publisher","first-page":"7319","DOI":"10.1073\/pnas.1324151111","volume":"111","author":"L HSIEH C","year":"2014","unstructured":"Hsieh CL, Fei T, Chen Y, et al. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation. Proc Natl Acad Sci U S A. 2014;111(20):7319\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15675_CR20","doi-asserted-by":"crossref","unstructured":"Pletcher A, Shibata M. Prostate organogenesis. Development. 2022;149(12).","DOI":"10.1242\/dev.200394"},{"key":"15675_CR21","doi-asserted-by":"crossref","unstructured":"Bushman W. Hedgehog signaling in prostate Development, regeneration and cancer. J Dev Biology. 2016;4(4).","DOI":"10.3390\/jdb4040030"},{"issue":"6","key":"15675_CR22","doi-asserted-by":"publisher","first-page":"4980","DOI":"10.1016\/j.ygeno.2020.08.034","volume":"112","author":"L GAO","year":"2020","unstructured":"Gao L, Meng J, Zhang Y, et al. Development and validation of a six-RNA binding proteins prognostic signature and candidate drugs for prostate cancer. Genomics. 2020;112(6):4980\u201392.","journal-title":"Genomics"},{"issue":"15","key":"15675_CR23","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1158\/1078-0432.CCR-17-3673","volume":"24","author":"BHANVADIARR VANOPSTALL","year":"2018","unstructured":"Vanopstall Bhanvadiarr, Brechka C. Meis1 and Meis2 expression and prostate cancer progression: A role for HOXB13 binding partners in metastatic disease. Clin Cancer Research: Official J Am Association Cancer Res. 2018;24(15):3668\u201380.","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"issue":"34","key":"15675_CR24","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.1038\/s41388-020-01389-7","volume":"39","author":"S WHITLOCK N C, TROSTEL S Y, WILKINSO","year":"2020","unstructured":"Whitlock NC, Trostel SY, Wilkinson S, et al. Meis1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity. Oncogene. 2020;39(34):5663\u201374.","journal-title":"Oncogene"},{"issue":"Pt 1","key":"15675_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.semcancer.2019.03.004","volume":"67","author":"D GRIMM","year":"2020","unstructured":"Grimm D, Bauer J, Wise P, et al. The role of SOX family members in solid tumours and metastasis. Sem Cancer Biol. 2020;67(Pt 1):122\u201353.","journal-title":"Sem Cancer Biol"},{"key":"15675_CR26","doi-asserted-by":"crossref","unstructured":"Zhou J, Yang X, Song P, et al. Hoxc6 in the prognosis of prostate cancer. Artif Cells Nanomed Biotechnol. 2019;47(1):2715\u201320.","DOI":"10.1080\/21691401.2019.1635136"},{"issue":"2","key":"15675_CR27","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1155\/2009\/568431","volume":"26","author":"RD MITTAL","year":"2009","unstructured":"Mittal RD, Kesarwani P, Singh R, et al. Gstm1, Gstm3 and Gstt1 gene variants and risk of benign prostate hyperplasia in North India. Dis Markers. 2009;26(2):85\u201391.","journal-title":"Dis Markers"},{"key":"15675_CR28","doi-asserted-by":"crossref","unstructured":"Lopez-Bujanda ZA, Obradovic A, Nirschl T R, et al. Tgm4: an Immunogenic prostate-restricted antigen. J Immunother Cancer. 2021;9(6).","DOI":"10.1136\/jitc-2020-001649"},{"issue":"6","key":"15675_CR29","doi-asserted-by":"publisher","first-page":"e426","DOI":"10.1002\/ctm2.426","volume":"11","author":"C LANG","year":"2021","unstructured":"Lang C, Yin C, Lin K, et al. m(6) A modification of LncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clin Translational Med. 2021;11(6):e426.","journal-title":"Clin Translational Med"},{"issue":"2","key":"15675_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K FEARON","year":"2013","unstructured":"Fearon K, Arends J. Understanding the mechanisms and treatment options in cancer cachexia. Nat Reviews Clin Oncol. 2013;10(2):90\u20139.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"7","key":"15675_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"PRADO C M","year":"2008","unstructured":"Prado CM, Lieffers JR, Mccargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and Gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9(7):629\u201335.","journal-title":"Lancet Oncol"},{"issue":"2","key":"15675_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.canlet.2012.09.017","volume":"328","author":"M KATOH","year":"2013","unstructured":"Katoh M, Igarashi M, Fukuda H, et al. Cancer genetics and genomics of human FOX family genes. Cancer Lett. 2013;328(2):198\u2013206.","journal-title":"Cancer Lett"},{"issue":"1","key":"15675_CR33","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/s41467-021-21976-w","volume":"12","author":"B ZHANG","year":"2021","unstructured":"Zhang B, Li Y, Wu Q, et al. Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer. Nat Commun. 2021;12(1):1714.","journal-title":"Nat Commun"},{"issue":"1","key":"15675_CR34","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/s41392-021-00583-7","volume":"6","author":"W GUO","year":"2021","unstructured":"Guo W, Zhang J, Zhou Y, et al. GPR160 is a potential biomarker associated with prostate cancer. Signal Transduct Target Ther. 2021;6(1):241.","journal-title":"Signal Transduct Target Therapy"},{"issue":"7","key":"15675_CR35","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/cbin.11802","volume":"46","author":"W YANG","year":"2022","unstructured":"Yang W, Wu W, Liang H, et al. Tox3 regulates the proliferation and apoptosis of colorectal cancer by downregulating RhoB via the activation of the MAPK pathway. Cell Biol Int. 2022;46(7):1074\u201388.","journal-title":"Cell Biol Int"},{"key":"15675_CR36","doi-asserted-by":"publisher","first-page":"105373","DOI":"10.1016\/j.tiv.2022.105373","volume":"82","author":"D LEE","year":"2022","unstructured":"Lee D, Lee PC, Hong JH, et al. Estrogen treatment reduced oxalate transporting activity and enhanced migration through the involvement of SLC26A6 in lung cancer cells. Toxicol Vitro: Int J Published Association BIBRA. 2022;82:105373.","journal-title":"Toxicol Vitro: Int J Published Association BIBRA"},{"key":"15675_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.omtn.2020.05.008","volume":"21","author":"G SHAN","year":"2020","unstructured":"Shan G, Shao B, Liu Q, et al. circFMN2 sponges miR-1238 to promote the expression of LIM-Homeobox gene 2 in prostate cancer cells. Mol Therapy Nucleic Acids. 2020;21:133\u201346.","journal-title":"Mol Therapy Nucleic Acids"},{"issue":"6","key":"15675_CR38","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s41418-021-00913-w","volume":"29","author":"Q SHI","year":"2022","unstructured":"Shi Q, Jin X, Zhang P, et al. SPOP mutations promote p62\/SQSTM1-dependent autophagy and Nrf2 activation in prostate cancer. Cell Death Differ. 2022;29(6):1228\u201339.","journal-title":"Cell Death Differ"},{"issue":"3","key":"15675_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2021.10.036","volume":"81","author":"J MAXWELL K N, CHENG H H, POWERS","year":"2022","unstructured":"Maxwell KN, Cheng HH, Powers J, et al. Inherited TP53 variants and risk of prostate cancer. Eur Urol. 2022;81(3):243\u201350.","journal-title":"Eur Urol"},{"key":"15675_CR40","doi-asserted-by":"crossref","unstructured":"Teng M, Zhou S, Cai C, et al. Pioneer of prostate cancer: past, present and the future of FOXA1. Protein Cell. 2021;12(1):29\u201338.","DOI":"10.1007\/s13238-020-00786-8"},{"issue":"1","key":"15675_CR41","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1038\/s41467-019-13532-4","volume":"10","author":"Q LI","year":"2019","unstructured":"Li Q, Liu B, Chao HP, et al. Lrig1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nat Commun. 2019;10(1):5494.","journal-title":"Nat Commun"},{"issue":"5","key":"15675_CR42","doi-asserted-by":"publisher","first-page":"3968","DOI":"10.1002\/jcp.26176","volume":"233","author":"F SOOZANGAR N, SADEGHI M R, JEDDI","year":"2018","unstructured":"Soozangar N, Sadeghi MR, Jeddi F, et al. Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer. J Cell Physiol. 2018;233(5):3968\u201381.","journal-title":"J Cell Physiol"},{"issue":"4","key":"15675_CR43","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.jhep.2020.11.008","volume":"74","author":"M ARECHEDERRA","year":"2021","unstructured":"Arechederra M, Bazai SK, Abdouni A, et al. Adamtsl5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinoma. J Hepatol. 2021;74(4):893\u2013906.","journal-title":"J Hepatol"},{"issue":"3","key":"15675_CR44","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.celrep.2016.03.038","volume":"15","author":"Y ZHAO","year":"2016","unstructured":"Zhao Y, Wang L, Ren S, et al. Activation of P-TEFb by androgen Receptor-Regulated enhancer RNAs in Castration-Resistant prostate cancer. Cell Rep. 2016;15(3):599\u2013610.","journal-title":"Cell Rep"},{"issue":"4","key":"15675_CR45","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.7150\/thno.51931","volume":"11","author":"S PAN C W, WEN","year":"2021","unstructured":"Pan CW, Wen S. Functional roles of antisense enhancer RNA for promoting prostate cancer progression. Theranostics. 2021;11(4):1780\u201394.","journal-title":"Theranostics"},{"issue":"2","key":"15675_CR46","doi-asserted-by":"publisher","first-page":"596","DOI":"10.7150\/thno.78687","volume":"13","author":"Y ZHAO","year":"2023","unstructured":"Zhao Y, Wen S, Li H, et al. Enhancer RNA promotes resistance to radiotherapy in bone-metastatic prostate cancer by m(6)A modification. Theranostics. 2023;13(2):596\u2013610.","journal-title":"Theranostics"},{"issue":"8","key":"15675_CR47","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1002\/ijc.33132","volume":"147","author":"Y WU","year":"2020","unstructured":"Wu Y, Yang Y, Gu H, et al. Multi-omics analysis reveals the functional transcription and potential translation of enhancers. Int J Cancer. 2020;147(8):2210\u201324.","journal-title":"Int J Cancer"},{"key":"15675_CR48","doi-asserted-by":"publisher","first-page":"1149997","DOI":"10.3389\/fendo.2023.1149997","volume":"14","author":"L WANG","year":"2023","unstructured":"Wang L, Wei C, Wang Y, et al. Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors. Front Endocrinol. 2023;14:1149997.","journal-title":"Front Endocrinol"},{"issue":"8","key":"15675_CR49","doi-asserted-by":"publisher","first-page":"110418","DOI":"10.1016\/j.celrep.2022.110418","volume":"38","author":"N NB","year":"2022","unstructured":"Nb N, Js An. Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors. Cell Rep. 2022;38(8):110418.","journal-title":"Cell Rep"},{"key":"15675_CR50","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.canlet.2021.11.001","volume":"526","author":"L CS","year":"2022","unstructured":"Cs L. Nucleoporin 93 mediates \u03b2-catenin nuclear import to promote hepatocellular carcinoma progression and metastasis. Cancer Lett. 2022;526:236\u201347.","journal-title":"Cancer Lett"},{"issue":"6598","key":"15675_CR51","doi-asserted-by":"publisher","first-page":"eabm9129","DOI":"10.1126\/science.abm9129","volume":"376","author":"B CJ","year":"2022","unstructured":"Cj B, S N. Architecture of the cytoplasmic face of the nuclear pore. Science. 2022;376(6598):eabm9129.","journal-title":"Science"},{"issue":"8","key":"15675_CR52","doi-asserted-by":"publisher","first-page":"110418","DOI":"10.1016\/j.celrep.2022.110418","volume":"38","author":"NB NATARAJ","year":"2022","unstructured":"Nataraj NB, Lee Noronhaa. Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors. Cell Rep. 2022;38(8):110418.","journal-title":"Cell Rep"},{"issue":"9","key":"15675_CR53","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1038\/s41418-018-0241-1","volume":"26","author":"L HJ","year":"2019","unstructured":"Hj L, Yh J, Jy O, et al. BICD1 mediates HIF1\u03b1 nuclear translocation in mesenchymal stem cells during hypoxia adaptation. Cell Death Differ. 2019;26(9):1716\u201334.","journal-title":"Cell Death Differ"},{"issue":"5","key":"15675_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.tcb.2016.01.001","volume":"26","author":"H CC","year":"2016","unstructured":"Cc H, Biology A A J T I C. Bicaudal D. Family of motor adaptors: linking dynein motility to cargo binding. Trends Cell Biol. 2016;26(5):327\u201340.","journal-title":"Trends Cell Biol"},{"issue":"5","key":"15675_CR55","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ccell.2020.08.020","volume":"38","author":"H CHEN","year":"2020","unstructured":"Chen H. A High-Resolution map of human enhancer RNA loci characterizes Super-enhancer activities in cancer. Cancer Cell. 2020;38(5):701\u201315.e5.","journal-title":"Cancer Cell"},{"key":"15675_CR56","doi-asserted-by":"crossref","unstructured":"S Z, J W, Q L, et al. PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets. Mol Cell. 2022;82(23):4428\u2013e427.","DOI":"10.1016\/j.molcel.2022.10.025"},{"key":"15675_CR57","doi-asserted-by":"crossref","unstructured":"Dt Ag JR. Super-enhancer mediated regulation of adult \u03b2-globin gene expression: the role of eRNA and integrator. Nucleic Acids Res. 2021;49(3):1383\u201396.","DOI":"10.1093\/nar\/gkab002"},{"issue":"4","key":"15675_CR58","doi-asserted-by":"publisher","first-page":"e13202","DOI":"10.1111\/cpr.13202","volume":"55","author":"Z HAN","year":"2022","unstructured":"Han Z, Li W, Enhancer RNA. What we know and what we can achieve. Cell Prolif. 2022;55(4):e13202.","journal-title":"Cell Prolif"},{"issue":"11","key":"15675_CR59","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1080\/15476286.2020.1712895","volume":"17","author":"JH LEE","year":"2020","unstructured":"Lee JH, Xiong F, LI W. Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential. RNA Biol. 2020;17(11):1550\u20139.","journal-title":"RNA Biol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-15675-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15675-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-15675-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:03:10Z","timestamp":1773756190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-15675-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15675"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-15675-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"27 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"354"}}